Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term studies in animals to evaluate carcinogenic potential have not been done
It is commonly used during preparation workflows where accurate dilution, reconstitution, and clean handling are required
How to administer an injection
Results at 72 weeks: Placebo: 3.1% weight loss Tirzepatide 5 mg: 16.0% weight loss (35.3 pounds average) Tirzepatide 10 mg: 21.4% weight loss (49.7 pounds average) Tirzepatide 15 mg: 22.5% weight loss (52.3 pounds average) The percentage of participants achieving 5% or more weight loss was 89% (5 mg), 96% (10 mg), and 96% (15 mg)
Still investigational: not FDA-approved, and patient counseling must reflect this
In vitro effects of cadmium and nickel on glutathione, lipid peroxidation and glutathione S-transferase in research-subject kidney